BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics.

Exelixis and Ipsen to seek approval for Cabometyx in prostate cancer – Pharmaceutical Technology

Combination treatment of Cabometyx and Tecentriq is being investigated in cancer indications as part of a research agreement between Exelixis and Roche. Image Credit: Gorodenkoff

August 21, 2023

Women with certain job roles may be associated with heightened risk of ovarian cancer

Hairdressers, beauticians, and accountants are among certain job roles that may be associated with a heightened risk of ovarian cancer, finds a case-control study published

July 11, 2023

Telehealth startup Done’s execs arrested and charged for alleged Adderall scheme, DOJ says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.